When it comes to medical devices, manufacturers and contractors must secure the compliance of their products before and after commercial launch to the market. Read more about how PureLabPlastics integrates the Scientific Injection Molding (SIM) approach in its contract-manufacturing service offerings to meet the growing regulatory requirements.
At PureLab Plastics, we are committed to the environment and developing sustainable practices with our suppliers. Learn more in this interview with Devicemed on the implementation of our eco-design approach across our entire value chain.
PureLab Plastics was created following the acquisition of the company Thomas and the sale of activities outside the medical sector. Newly renovated, the company covers a surface area of 7,000m² including a climate- and dust-controlled plastic molding workshop with 30 injection molding machines, 17 of which are electric, two clean rooms meeting ISO 7 and ISO 8 standards and machining, assembly and packaging stations for mass production from 200 to 1 million units per week.
PureLab Plastics is also a key player in the medical market and carries out its production in a controlled atmosphere that meets ISO 7 and ISO 8 standards, in keeping with the requirements of its customers in the medical domain, and in compliance with regulations and the ISO 1
PureLab Plastics develops and manufactures robust, ergonomic and functional plastic components and instruments that meet customers’ requirements for application in research, diagnostics, labwater, biomonitoring and bioprocessing.
PureLab Plastics is excited to take part in Pharmapack Europe, the leading European event for key players in drug packaging and drug delivery systems in the pharmaceutical sector.
Visit us at booth D52 in Paris Expo, Porte de Versailles, on February 5-6, 2020. We look forward to speaking with you!